Q1: 2026-05-06 Earnings Summary EPS of -$0.16 beats by $0.26  |  Revenue of $162.05M (106.87% Y/Y) beats by $14.26M Tarsus Pharmaceuticals, Inc. ( TARS ) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT Company Participants Jeffrey S. Farrow - CFO & Chief Strategy Officer Aziz Mottiwala - Chief Commercial Officer Conference Call Participants Jason Gerberry - BofA Securities, Research Division Presentation Jason Gerberry BofA Securities, Research Division Going here with our next company presenter at the BofA Annual Healthcare Conference in Nevada. We've got Tarsus Pharmaceuticals, Jeff Farrow, CFO; and Aziz Mottiwala, Chief Commercial Officer. I'm Jason Gerberry, I cover biotech and pharma at BofA. We've been covering you guys for a couple of years now. You're kind of hitting a real inflection point with the commercial launch of XDEMVY for Demodex blepharitis.…